Progress 07/01/15 to 09/30/17
Outputs Target Audience:Preliminary results of these studies have been shared with a national audience at the Experimental Biology meeting in April 2017 as well as with principle investogators, scientists, community partners, and students at Oklahoma State University through open seminar and poster presentations. An undergraduate research scholar, who was obtained funding independent of this project also worked on the project and presented results of these studies at a university-wide undergraduate research forum in October 2017. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?One undergraduate scholar and two graduate students have been trained during the completion of this project. Training included not only experimental design, data collection and analysis, and interpretation, but also the ability to read and crtitique existing research. Students also gained critical experience in disseminating experimental findings in both written and verbal formats. Students involved in the project participated and presented their research at both local and national conferences. How have the results been disseminated to communities of interest?The results from this project have been presented at university-wide research conferences as well as a national conference (annual meeting of the American Society for Nutrition/Experimental Biology 2017). Additionally, this project served as the basis of a graduate student's thesis submitted in November 2017. What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
As a result of the studies conducted during the completion of this project, we gained insight into the role(s) of compounds enriched in garlic on the regulation of cholesterol metabolism in cells. In particular, we confirmed that cells treated with garlic-derived compounds increase the expression of genes involved in promoting cholesterol removal from cells. These results confirm previously published studies demonstrating the garlic consumption reduces serum cholesterol thereby reducing cardiovascular disease risk. Although we originally predicted that these garlic-derived compounds increase cholesterol removal by increasing the expression of ABCA1 (a protein that promotes cholesterol efflux from cells) through a mechanism involving chromatin remodeling, it does not appear that ABCA1 expression is increased by modification in histones and chromatin remodeling. We continue to examine other potential mechanisms through which these garlic-derived compounds may exert cardioprotective benefits by promoting cholesterol efflux and stimulating reverse-cholesterol transport. APPROACH: To examine the impact of garlic-derived compounds on ABCA1 gene expression, mouse macrophage-like cells (RAW 264.7) were treated with diallyl disulfide (DADS), allyl mercaptan (AM), and S-allyl-cysteine (SAC). Following treatment, total RNA was isolated and reverse-transcribed to examine ABCA1 gene expression by quantitative real-time PCR. Additionally, cells were treated and prepared for Chromatin-Immunoprecipitation (ChIP) analysis to examine histone modification. In addition to DADS, AM, and SAC, cells were treated with the histone deacetylase inhibitor Trichostatin A (TSA) which serves as a positive control for assessing histone modification and chromatin-remodeling. Finally, the activation of the ABCA1 promoter was assessed by heterologous luciferase reporter assays. RESULTS: The expression of ABCA1 was increased 3-7-fold in cells treated with DADS, AM, SAC, and TSA compared to control cells. These results indicate that these compounds may exhibit a cardioprotective benefit in macrophages by increasing the expression of ABCA1 - the protein responsible for cholesterol efflux in macrophages, Next, ChIP assays indicated that the abundance of modified histones (acetylated H3 and H4 compared to total H3 and H4) was unchanged in cells treated with DADS, AM, and SAC but increased in cells treated with TSA. These results suggest that the garlic-derived compounds modulate ABCA1 expression in a manner independent of histone modification. To begin to assess the regualtion of the ABCA1 promoter, reporter assays were utilized, Interestingly, treatment of cells with DADS increased reporter activity compared to control cells or cells treated with TSA suggesting that there may be a more direct effect of these compounds on increasing ABCA1 expression directly through an unknown mechanism controlling the ABCA1 promoter. IMPLICATIONS: Previous work has suggested that DADS, AM, and SAC exhibit the ability to participate in histone modification, though these studies focused primarily on some of the putative anti-cancer properties of these compounds. In our work, we did not obtain any evidence that the ability of these compounds to increase ABCA1 gene expression was mediated by histone modification or chromatin remodeling. Although we were unable to identify the moelcular mechanism through which DADS, AM, and SAC modulate ABCA1 gene expression, we again confirmed that these compounds play a significant role in increasing ABCA1 expression in cells and could play a central role in promoting reverse-cholesterol transport to reduce cardiovascular disease risk. Therefore, the use of garlic and/or its bioactive components remain an attractive target to investigate for the incorporation of garlic into the diet to reduce serum cholesterol and reduce disease risk.
Publications
- Type:
Theses/Dissertations
Status:
Published
Year Published:
2017
Citation:
Madden AJ, Krehbiel MD, and Clarke SL. 2017, 'Organosulfur garlic-derived compounds induce ABCA1 gene expression in RAW 264.7 cells', M.S.in Nutritional Sciences, Oklahoma State University, Stillwater, OK.
- Type:
Conference Papers and Presentations
Status:
Accepted
Year Published:
2017
Citation:
Abbie J. Madden, Madison D. Krehbiel, and Stephen L. Clarke. Nutrition - Cardiovascular Effects of Dietary Bioactive Components. Garlic-derived Compounds Increase Expression of ABCA1 mRNA in RAW 264.7 Murine Macrophages
FASEB J April 2017 31:973.1
|